Incidence and Risk of Fatal Adverse Events in Cancer Patients Treated With Vascular Endothelial Growth Factor Receptor 2-Targeted Agents: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials

Lignende værker

• Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
  af: Zhao, Bin, et al.
  Udgivet: (2018)
• Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
  af: Zhao, Bin, et al.
  Udgivet: (2019)
• Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
  af: Zhao, Bin, et al.
  Udgivet: (2020)
• Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC
  af: Zhu, Qian, et al.
  Udgivet: (2017)
• Sequential Surgical Procedures in Vascular Surgery Patients Are Associated With Perioperative Adverse Cardiac Events
  af: Janssen, Henrike, et al.
  Udgivet: (2020)